Ray Dalio's HCA Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 340,557 shares of HCA Healthcare, Inc. (HCA) worth $145.15 M, representing 0.57% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in HCA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 220,512 shares. Largest reduction occurred in Q3 2022, reducing 123,477 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's HCA Healthcare (HCA) Holding Value Over Time
Track share changes against reported price movement
Quarterly HCA Healthcare (HCA) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2020 | +18,582 | New Buy | 18,582 | $89.87 |
| Q2 2020 | -6,279 | Reduce 33.79% | 12,303 | $97.05 |
| Q3 2020 | +60,482 | Add 491.60% | 72,785 | $124.68 |
| Q4 2020 | +94,121 | Add 129.31% | 166,906 | $164.46 |
| Q1 2021 | -4,223 | Reduce 2.53% | 162,683 | $188.34 |
| Q2 2021 | +121,089 | Add 74.43% | 283,772 | $206.74 |
| Q3 2021 | +57,603 | Add 20.30% | 341,375 | $242.72 |
| Q4 2021 | -28,510 | Reduce 8.35% | 312,865 | $256.92 |
| Q1 2022 | +76,485 | Add 24.45% | 389,350 | $250.62 |
| Q2 2022 | +106,167 | Add 27.27% | 495,517 | $168.06 |
| Q3 2022 | -123,477 | Reduce 24.92% | 372,040 | $183.79 |
| Q4 2022 | -26,585 | Reduce 7.15% | 345,455 | $239.96 |
| Q1 2023 | -4,720 | Reduce 1.37% | 340,735 | $263.68 |
| Q2 2023 | -37,992 | Reduce 11.15% | 302,743 | $303.48 |
| Q3 2023 | +72,965 | Add 24.10% | 375,708 | $245.98 |
| Q4 2023 | +50,568 | Add 13.46% | 426,276 | $270.68 |
| Q1 2024 | -79,963 | Reduce 18.76% | 346,313 | $333.53 |
| Q2 2024 | -50,415 | Reduce 14.56% | 295,898 | $321.28 |
| Q3 2024 | -45,857 | Reduce 15.50% | 250,041 | $406.43 |
| Q4 2024 | +220,512 | Add 88.19% | 470,553 | $300.15 |
| Q1 2025 | -41,827 | Reduce 8.89% | 428,726 | $345.55 |
| Q2 2025 | -22,020 | Reduce 5.14% | 406,706 | $383.10 |
| Q3 2025 | -66,149 | Reduce 16.26% | 340,557 | $426.20 |
Ray Dalio's HCA Healthcare Investment FAQs
Ray Dalio first purchased HCA Healthcare, Inc. (HCA) in Q1 2020, acquiring 18,582 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held HCA Healthcare, Inc. (HCA) for 23 quarters since Q1 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to HCA Healthcare, Inc. (HCA) was in Q4 2024, adding 470,553 shares worth $141.24 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 340,557 shares of HCA Healthcare, Inc. (HCA), valued at approximately $145.15 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, HCA Healthcare, Inc. (HCA) represents approximately 0.57% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in HCA Healthcare, Inc. (HCA) was 495,517 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.